1. Academic Validation
  2. A homozygous loss-of-function mutation leading to CYBC1 deficiency causes chronic granulomatous disease

A homozygous loss-of-function mutation leading to CYBC1 deficiency causes chronic granulomatous disease

  • Nat Commun. 2018 Oct 25;9(1):4447. doi: 10.1038/s41467-018-06964-x.
Gudny A Arnadottir 1 Gudmundur L Norddahl 1 Steinunn Gudmundsdottir 1 Arna B Agustsdottir 1 Snaevar Sigurdsson 1 Brynjar O Jensson 1 Kristbjorg Bjarnadottir 1 Fannar Theodors 1 Stefania Benonisdottir 1 Erna V Ivarsdottir 1 2 Asmundur Oddsson 1 Ragnar P Kristjansson 1 Gerald Sulem 1 Kristjan F Alexandersson 1 Thorhildur Juliusdottir 1 Kjartan R Gudmundsson 1 Jona Saemundsdottir 1 Adalbjorg Jonasdottir 1 Aslaug Jonasdottir 1 Asgeir Sigurdsson 1 Paolo Manzanillo 1 Sigurjon A Gudjonsson 1 Gudmundur A Thorisson 1 Olafur Th Magnusson 1 Gisli Masson 1 Kjartan B Orvar 3 4 Hilma Holm 1 Sigurdur Bjornsson 3 4 Reynir Arngrimsson 5 6 Daniel F Gudbjartsson 1 2 Unnur Thorsteinsdottir 1 6 Ingileif Jonsdottir 1 6 Asgeir Haraldsson 6 7 Patrick Sulem 8 Kari Stefansson 9 10
Affiliations

Affiliations

  • 1 deCODE Genetics/Amgen, Inc., Reykjavik, Iceland.
  • 2 School of Engineering and Natural Sciences, University of Iceland, Reykjavik, Iceland.
  • 3 Department of Internal Medicine, Landspitali University Hospital, Reykjavik, Iceland.
  • 4 The Medical Center, Glaesibae, Reykjavik, Iceland.
  • 5 Department of Genetics and Molecular Medicine, Landspitali University Hospital, Reykjavik, Iceland.
  • 6 Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
  • 7 Children's Hospital Iceland, Landspitali University Hospital, Reykjavik, Iceland.
  • 8 deCODE Genetics/Amgen, Inc., Reykjavik, Iceland. [email protected].
  • 9 deCODE Genetics/Amgen, Inc., Reykjavik, Iceland. [email protected].
  • 10 Faculty of Medicine, University of Iceland, Reykjavik, Iceland. [email protected].
Abstract

Mutations in genes encoding subunits of the phagocyte NADPH Oxidase complex are recognized to cause chronic granulomatous disease (CGD), a severe primary immunodeficiency. Here we describe how deficiency of CYBC1, a previously uncharacterized protein in humans (C17orf62), leads to reduced expression of NADPH oxidase's main subunit (gp91phox) and results in CGD. Analyzing two brothers diagnosed with CGD we identify a homozygous loss-of-function mutation, p.Tyr2Ter, in CYBC1. Imputation of p.Tyr2Ter into 155K chip-genotyped Icelanders reveals six additional homozygotes, all with signs of CGD, manifesting as colitis, rare infections, or a severely impaired PMA-induced neutrophil oxidative burst. Homozygosity for p.Tyr2Ter consequently associates with inflammatory bowel disease (IBD) in Iceland (P = 8.3 × 10-8; OR = 67.6), as well as reduced height (P = 3.3 × 10-4; -8.5 cm). Overall, we find that CYBC1 deficiency results in CGD characterized by colitis and a distinct profile of infections indicative of macrophage dysfunction.

Figures